Division of Nephrology, Department of Medicine, Albert Einstein College of Medicine, Room 615, Ullmann Building, 1300 Morris Park Ave, Bronx, NY 10461, USA.
Nephrol Dial Transplant. 2010 May;25(5):1608-13. doi: 10.1093/ndt/gfp629. Epub 2009 Dec 17.
Dialysis adequacy is currently judged by measures of urea clearance. However, urea is relatively non-toxic and has properties distinct from large classes of other retained solutes. In particular, intracellularly sequestered solutes are likely to behave differently than urea.
We studied an example of this class, the aliphatic amine monomethylamine (MMA), in stable haemodialysis outpatients (n = 10) using an HPLC-based assay.
Mean MMA levels pre-dialysis in end-stage renal disease subjects were 76 +/- 15 microg/L compared to 32 +/- 4 microg/L in normal subjects (n = 10) (P < 0.001). Mean urea reduction was 62% while the reduction ratio for MMA was 43% (P < 0.01). MMA levels rebounded in the 1 hour post-dialytic period to 85% of baseline, whereas urea levels rebounded only to 47% of baseline. MMA had a much larger calculated volume of distribution compared to urea, consistent with intracellular sequestration. Measures of intra-red blood cell (RBC) MMA concentrations confirmed greater levels in RBCs than in plasma with a ratio of 4.9:1. Because of the intracellular sequestration of MMA, we calculated its clearance using that amount removed from whole blood. Clearances for urea averaged 222 +/- 41 ml/min and for MMA 121 +/- 14 ml/min, while plasma clearance for creatinine was 162 +/- 20 ml/min (P < 0.01, for all differences). Using in vitro dialysis, in the absence of RBCs, solute clearance rates were similar: 333 +/- 6, 313 +/- 8 and 326 +/- 4 ml/min for urea, creatinine and MMA, respectively. These findings suggest that the lower MMA clearance relative to creatinine in vivo is a result of MMA movement into RBCs within the dialyser blood path diminishing its removal by dialysis.
In conclusion, we find that, in conventional haemodialysis, MMA is not cleared as efficiently as urea or creatinine and raise the possibility that RBCs may limit its dialysis not merely by failing to discharge it, but by further sequestering it as blood passes through the dialyser.
目前,透析充分性通过尿素清除率来判断。然而,尿素的毒性相对较低,并且与其他大量保留溶质的性质不同。特别是,细胞内隔离的溶质可能与尿素的行为不同。
我们使用基于 HPLC 的测定方法,在稳定的血液透析门诊患者(n = 10)中研究了这一类的一个例子,即脂肪胺单甲基胺(MMA)。
终末期肾病患者透析前 MMA 的平均水平为 76 ± 15 µg/L,而正常受试者(n = 10)为 32 ± 4 µg/L(P < 0.001)。平均尿素清除率为 62%,而 MMA 的降低率为 43%(P < 0.01)。MMA 在透析后 1 小时内反弹至基线的 85%,而尿素水平仅反弹至基线的 47%。MMA 的计算分布体积比尿素大得多,这与细胞内隔离一致。红细胞内(RBC)MMA 浓度的测量结果证实,RBC 中的浓度高于血浆,比值为 4.9:1。由于 MMA 的细胞内隔离,我们使用从全血中去除的量来计算其清除率。尿素的清除率平均为 222 ± 41 ml/min,MMA 为 121 ± 14 ml/min,而肌酸酐的血浆清除率为 162 ± 20 ml/min(所有差异均为 P < 0.01)。在没有 RBC 的情况下进行体外透析时,溶质清除率相似:尿素、肌酸酐和 MMA 的清除率分别为 333 ± 6、313 ± 8 和 326 ± 4 ml/min。这些发现表明,MMA 在体内相对于肌酸酐的清除率较低,是因为 MMA 在透析器血液路径中进入 RBC,从而减少了其通过透析的清除。
总之,我们发现,在常规血液透析中,MMA 的清除效率不如尿素或肌酸酐高,并提出了 RBC 可能不仅通过未能排出 MMA,而且通过血液通过透析器时进一步隔离 MMA 来限制其透析的可能性。